Larvol Delta - Arcturus-Therapeutics-Announces-Initiation-of-Dosing-in-Phase-2-Multiple-Ascending-Dose-Studies-for-Cystic-Fibrosis-CF-and-Ornithine-Transcarbamylase-OTC-Deciency

ARCT-810 - Arcturus Therap

ARCT-032 - Arcturus Therap

https://www.businesswire.com/news/home/20250106386740/en/Arcturus-Therapeutics-Announces-Initiation-of-Dosing-in-Phase-2-Multiple-Ascending-Dose-Studies-for-Cystic-Fibrosis-CF-and-Ornithine-Transcarbamylase-OTC-Deficiency

Jan 6, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next